Intellipharmaceutics International Inc. (IPCI)

[wimuskyfisherman]

Here is a prediction. I am guessing 2018Q1 report will start back pedaling on the aggressive guidance the company gave early in 2018. There have been no announcements, nothing. I don't see how they won't start back pedaling on this guidance as the first 4 months of FY2018 there has been nothing. Even if HAP studies start today, that puts them at the end of September for completion. That would allow them 60 days to resubmit NDA in FY2018(end of November). So from all this I gather, the NDA will be resubmitted in 2019... Now how in the F*** can management justify this progress? There is no other developments going on??? So how can't they get the HAP studies done and the NDA resubmitted? I could understand if they would have said in January 2018 that they needed to reformulate Rexista without the blue dye and this will take a couple months and the HAP studies will start in April or May. But they did none of that. They just said they would start the studies right away and they would be done by September 2018... So it appears to me like management gave BS guidance without evaluating the situation first. The amount of incompetency within IPCI grows to new levels each and every day.

One other thing. Last year in October, management told me directly the HAP studies would commence within 60-90 days. I called them on this at about the 100th day. All I can say is I got some attitude. At that time, they told me that they were a little bit late but they were going to start soon. And they said this with attitude... Like I was the bad guy. Hey wait, you guys did not deliver once again and I am the bad guy?????